Pathstone Holdings LLC decreased its place in CME Group Inc. (NASDAQ:CME – Free Report) by 2.3% within the third quarter, based on the corporate in its most up-to-date 13F submitting with the SEC. The fund owned 38,540 shares of the monetary providers supplier’s inventory after promoting 899 shares through the interval. Pathstone Holdings LLC’s holdings in CME Group have been price $8,504,000 as of its most up-to-date submitting with the SEC.
A number of different hedge funds have additionally just lately modified their holdings of the corporate. Ameriprise Monetary Inc. boosted its holdings in shares of CME Group by 11.3% within the 2nd quarter. Ameriprise Monetary Inc. now owns 5,283,196 shares of the monetary providers supplier’s inventory price $1,038,676,000 after shopping for a further 537,758 shares over the last quarter. GUARDCAP ASSET MANAGEMENT Ltd raised its place in CME Group by 1.1% within the first quarter. GUARDCAP ASSET MANAGEMENT Ltd now owns 4,009,068 shares of the monetary providers supplier’s inventory price $863,112,000 after buying a further 43,293 shares through the interval. Raymond James & Associates boosted its stake in CME Group by 3.2% within the second quarter. Raymond James & Associates now owns 3,029,145 shares of the monetary providers supplier’s inventory valued at $595,530,000 after buying a further 94,302 shares over the last quarter. Authorized & Basic Group Plc grew its place in shares of CME Group by 6.6% through the 2nd quarter. Authorized & Basic Group Plc now owns 2,835,075 shares of the monetary providers supplier’s inventory valued at $557,371,000 after buying a further 176,004 shares through the interval. Lastly, PineStone Asset Administration Inc. elevated its stake in shares of CME Group by 137.6% through the 2nd quarter. PineStone Asset Administration Inc. now owns 2,260,644 shares of the monetary providers supplier’s inventory price $444,443,000 after buying a further 1,309,097 shares over the last quarter. Institutional traders personal 87.75% of the corporate’s inventory.
CME Group Inventory Down 0.5 %
CME opened at $226.96 on Friday. The agency has a market capitalization of $81.79 billion, a P/E ratio of 23.87, a price-to-earnings-growth ratio of 5.30 and a beta of 0.55. CME Group Inc. has a one yr low of $190.70 and a one yr excessive of $230.74. The corporate has a fifty day shifting common worth of $223.40 and a 200-day shifting common worth of $210.92. The corporate has a debt-to-equity ratio of 0.09, a present ratio of 1.02 and a fast ratio of 1.02.
CME Group (NASDAQ:CME – Get Free Report) final posted its earnings outcomes on Wednesday, October twenty third. The monetary providers supplier reported $2.68 EPS for the quarter, topping the consensus estimate of $2.65 by $0.03. CME Group had a return on fairness of 13.39% and a web margin of 57.34%. The enterprise had income of $1.58 billion through the quarter, in comparison with analysts’ expectations of $1.59 billion. Throughout the identical interval within the earlier yr, the enterprise earned $2.25 earnings per share. The agency’s income was up 18.4% on a year-over-year foundation. Equities analysis analysts count on that CME Group Inc. will submit 10.22 earnings per share for the present fiscal yr.
CME Group Pronounces Dividend
The enterprise additionally just lately introduced a quarterly dividend, which shall be paid on Friday, December twenty seventh. Traders of document on Monday, December ninth shall be paid a $1.15 dividend. This represents a $4.60 dividend on an annualized foundation and a yield of two.03%. The ex-dividend date of this dividend is Monday, December ninth. CME Group’s dividend payout ratio is at the moment 48.37%.
Insider Exercise
In different information, Director Bryan T. Durkin bought 7,593 shares of the corporate’s inventory in a transaction on Friday, August thirtieth. The shares have been bought at a mean worth of $214.59, for a complete worth of $1,629,381.87. Following the completion of the sale, the director now owns 55,607 shares of the corporate’s inventory, valued at roughly $11,932,706.13. This represents a 12.01 % lower of their place. The sale was disclosed in a doc filed with the Securities & Alternate Fee, which is accessible via this hyperlink. Additionally, Director Martin J. Gepsman bought 400 shares of CME Group inventory in a transaction on Monday, November 4th. The inventory was bought at a mean worth of $222.92, for a complete transaction of $89,168.00. Following the completion of the transaction, the director now owns 25,067 shares within the firm, valued at roughly $5,587,935.64. The commerce was a 1.57 % lower of their place. The disclosure for this sale might be discovered right here. Within the final quarter, insiders have bought 15,621 shares of firm inventory price $3,441,063. 0.30% of the inventory is at the moment owned by company insiders.
Wall Road Analysts Forecast Development
A number of equities analysts have weighed in on the corporate. Financial institution of America elevated their worth goal on CME Group from $177.00 to $180.00 and gave the corporate an “underperform” ranking in a report on Thursday, October third. Redburn Atlantic downgraded CME Group from a “purchase” ranking to a “impartial” ranking and set a $244.00 worth goal for the corporate. in a analysis observe on Tuesday, October eighth. Citigroup boosted their worth goal on CME Group from $250.00 to $255.00 and gave the corporate a “purchase” ranking in a analysis observe on Thursday, October twenty fourth. Morgan Stanley elevated their goal worth on shares of CME Group from $210.00 to $233.00 and gave the inventory an “equal weight” ranking in a analysis report on Thursday, October seventeenth. Lastly, The Goldman Sachs Group boosted their worth goal on shares of CME Group from $195.00 to $198.00 and gave the corporate a “promote” ranking in a analysis report on Thursday, October third. 4 funding analysts have rated the inventory with a promote ranking, seven have assigned a maintain ranking and 4 have assigned a purchase ranking to the inventory. Based mostly on information from MarketBeat.com, CME Group presently has a consensus ranking of “Maintain” and a mean worth goal of $224.47.
Get Our Newest Inventory Evaluation on CME
CME Group Profile
CME Group Inc, along with its subsidiaries, operates contract markets for the buying and selling of futures and choices on futures contracts worldwide. It gives futures and choices merchandise primarily based on rates of interest, fairness indexes, international change, agricultural commodities, power, and metals, in addition to fastened earnings and international forex buying and selling providers.
Advisable Tales
Wish to see what different hedge funds are holding CME? Go to HoldingsChannel.com to get the newest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Obtain Information & Scores for CME Group Every day – Enter your electronic mail handle beneath to obtain a concise each day abstract of the newest information and analysts’ rankings for CME Group and associated firms with MarketBeat.com’s FREE each day electronic mail publication.
